Oncolytics Biotech
ONCY
Oncolytics Biotech (ONCY) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $5.00 from $10.00 | Aug 19, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | May 26, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 from $5.00 | Nov 17, 2025 |
| Lake Street | Initiated Coverage | Buy | $7.00 | Aug 13, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | May 21, 2025 |
| Jones Trading | Downgraded | Buy → Hold | — | May 16, 2025 |
| RBC Capital | Maintained | Outperform | $5.00 from $6.00 | Mar 10, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Mar 10, 2025 |
| Maxim Group | Maintained | Buy | $3.00 from $5.00 | Mar 10, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Feb 3, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Nov 14, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Sep 19, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Aug 21, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | May 14, 2024 |
| Raymond James | Initiated Coverage | Outperform | $3.00 | Apr 4, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Mar 8, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Feb 14, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Jan 19, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Jan 4, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 from $15.00 | Nov 13, 2023 |
Frequently asked questions
What is the latest analyst rating on ONCY?
On Aug 19, 2026, HC Wainwright & Co. maintained Oncolytics Biotech at Buy with a price target of $5.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.